中国科学技术大学翁建平--中文主页-- 38. Weng J*. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c>9. J Diabetes. 2017 Oct;9(10):890-893. https://doi.org/10.1111/1753-0407.12581.

教授
博士生导师
硕士生导师
电子邮箱：
职务：临床医学院执行院长、中国科学院临床研究医院（合肥）执行院长
学历：研究生(博士后)
学位：博士
主要任职：安徽医科大学校长

论文成果

当前位置: 中文主页 >> 科学研究 >> 论文成果

38. Weng J*. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c>9. J Diabetes. 2017 Oct;9(10):890-893. https://doi.org/10.1111/1753-0407.12581.

是否译文：否
发表时间：2021-09-03

上一条：39. Liang H, Xu W, Zhou L, Yang W, Weng J*. Differential increments of basal glucagon-like-1 peptide concentration among SLC47A1 rs2289669 genotypes were associated with inter-individual variability in glycaemic response to metformin in Chinese people with newly diagnosed Type 2 diabetes. Diabet Med. 2017 Jul;34(7):987-992. https://doi.org/10.1111/dme.13351.

下一条：37. Weng JP*, Hu G. Diabetes: Leveraging the Tipping Point of the Diabetes Pandemic. Diabetes. 2017 Jun;66(6):1461-1463. https://doi.org/10.2337/dbi16-0076.